Mirabaud & Cie’s BioNTech BNTX Stock Holding History

Mirabaud & Cie’s Portfolio BNTX Stock Details BNTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$558K	Hold	6,000	–	–	0.22%	38
2026 Q1	$533K	Hold	6,000	–	–	0.22%	41
2025 Q4	$571K	Hold	6,000	–	–	0.18%	48
2025 Q3	$592K	Hold	6,000	–	–	0.19%	49
2025 Q2	$639K	Hold	6,000	–	–	0.2%	48
2025 Q1	$546K	Hold	6,000	–	–	0.19%	47
2024 Q4	$684K	Buy	+6,000	New	+$685K	0.22%	47

Other funds holding BNTX

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Flossbach Von Storch Cologne, Germany $22.1B AUM 6.81% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Temasek Holdings Singapore $37.3B AUM 12.6% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return

LGM

Logos Global Management San Francisco, California $2.32B AUM 536.01% 1-Year Est. Return

GSK plc London $602M AUM

Mirabaud & Cie's BNTX Position: Q2 2026 in Review

Mirabaud & Cie held its BioNTech (BNTX) position steady in Q2 2026 at 6,000 shares worth $558K. The position accounts for 0.22% of the portfolio, ranked #38.

Mirabaud & Cie first reported a position in BNTX in Q4 2024 and has held it in 7 quarters since. The position peaked at $684K in Q4 2024. 283 funds tracked by Wall St. Rank hold BNTX as of Q2 2026.

Mirabaud & Cie held 6,000 shares of BioNTech worth $558K as of Q2 2026.
Mirabaud & Cie left its BioNTech share count unchanged in Q2 2026.
BioNTech made up 0.22% of Mirabaud & Cie's portfolio in Q2 2026, its #38 holding.
Mirabaud & Cie first reported a position in BioNTech in Q4 2024 and has held it in 7 quarters since.
Mirabaud & Cie's BioNTech position peaked at $684K in Q4 2024.
283 funds tracked by Wall St. Rank held BioNTech as of Q2 2026.

Based on Mirabaud & Cie's 13F filing for Q2 2026, filed 8 Jul 2026.